81.35
0.60 (0.74%)
| Penutupan Terdahulu | 80.75 |
| Buka | 80.53 |
| Jumlah Dagangan | 303,209 |
| Purata Dagangan (3B) | 978,663 |
| Modal Pasaran | 3,919,219,712 |
| Harga / Pendapatan (P/E TTM) | 23.79 |
| Harga / Pendapatan (P/E Ke hadapan) | 10.04 |
| Harga / Jualan (P/S) | 3.10 |
| Harga / Buku (P/B) | 4.63 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Feb 2026 |
| Margin Keuntungan | 12.32% |
| Margin Operasi (TTM) | 17.20% |
| EPS Cair (TTM) | 3.31 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -3.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 184.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 156.35% |
| Nisbah Semasa (MRQ) | 1.62 |
| Aliran Tunai Operasi (OCF TTM) | 181.72 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 183.89 M |
| Pulangan Atas Aset (ROA TTM) | 6.65% |
| Pulangan Atas Ekuiti (ROE TTM) | 18.83% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Haemonetics Corporation | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.25 |
|
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.10% |
| % Dimiliki oleh Institusi | 118.44% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 90.00 (Barrington Research, 10.63%) | Beli |
| Median | 83.00 (2.03%) | |
| Rendah | 64.00 (Citigroup, -21.33%) | Beli |
| Purata | 80.00 (-1.66%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 66.19 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 21 Nov 2025 | 88.00 (8.17%) | Beli | 78.79 |
| 06 Nov 2025 | 88.00 (8.17%) | Beli | 67.11 | |
| Barrington Research | 07 Nov 2025 | 90.00 (10.63%) | Beli | 68.36 |
| 21 Oct 2025 | 86.00 (5.72%) | Beli | 51.19 | |
| Needham | 07 Nov 2025 | 78.00 (-4.12%) | Beli | 68.36 |
| Citigroup | 07 Oct 2025 | 64.00 (-21.33%) | Beli | 49.26 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 Nov 2025 | Pengumuman | Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website |
| 09 Oct 2025 | Pengumuman | Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |